News Daily News Speed Still Critical for Endovascular Therapy Patients Treated Soon After Stroke: MR CLEAN Caitlin E. Cox March 30, 2018
News Conference News ISET 2018 WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy Caitlin E. Cox February 13, 2018
News Daily News Tool Predicts Stroke Risk in Patients With Systolic Dysfunction After MI Todd Neale February 12, 2018
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Four Shelley Wood November 02, 2017
News Features Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions? Todd Neale June 21, 2017
News Conference News ISC 2017 Big Fluctuations in Blood Pressure Signal a Higher Stroke Risk in Well-Controlled Hypertensives Todd Neale February 24, 2017
News Industry News Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke February 21, 2017
News Daily News Carotid Stenting Outcomes Not Linked to Hospital Case Volume in German Registry L.A. McKeown November 18, 2016
News Industry News TCT 2016 Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke November 01, 2016
Presentation TCT 2016 RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler November 01, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Industry News Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke September 08, 2016
News Daily News FDA Expands Indications for Two Endovascular Stroke Therapies Todd Neale September 06, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA Todd Neale April 21, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016